Development of novel predictive biomarkers for breast cancer with neoadjuvant chemotherapy
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000014479
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Ductal carcinoma in situ 2. Any past history of malignant disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare RNA expressions between breast cancers with complete response to neoadjuvant chemotherapy and tumors with non-complete responses for each subtype
- Secondary Outcome Measures
Name Time Method To compare RNA expressions in each breast cancer subtype